MT. LAUREL, N.J., March 2 /PRNewswire-FirstCall/ -- MedQuist Inc. (MEDQ.PK), today announced that it has named Frank W. Lavelle as its new President. Mr. Lavelle will report to Howard S. Hoffmann, who will continue to serve as Chief Executive Officer.
Mr. Lavelle most recently was President, Enterprise Sales & Marketing, Customer Solutions Group at Siemens Medical Solutions. He has held many senior positions including President & Chief Executive Officer of Siemens Medical Solutions Health Services Corporation and Senior Vice President, North American Customer Operations for Shared Medical Systems prior to its acquisition by Siemens. Mr. Lavelle will join MedQuist on March 8.
Mr. Lavelle replaces Greg Sebasky who has served as MedQuist’s President since February 2004. Mr. Sebasky has been asked to return to Philips Medical Systems, where he formerly held a senior position, to take on new executive responsibilities. MedQuist thanks Mr. Sebasky for his outstanding achievements in, among other things, improving MedQuist’s internal communication efforts, initiating the transformation of the company to a customer-facing company as well as rebuilding the company’s management team. Mr. Sebasky will remain at MedQuist for a brief transitional period to ensure that critical knowledge is transferred and that the positive momentum which the company has enjoyed over the last few months is maintained.
About MedQuist:
MedQuist, a member of the Philips Group of Companies, is a leading provider of electronic medical transcription, health information and document management products and services. MedQuist provides document workflow management, digital dictation, speech recognition, mobile dictation devices, Web-based transcription, electronic signature, medical coding products and outsourcing services.
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist’s business which are not historical facts are “forward-looking statements” that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward- looking statements, see “Risk Factors” in the Company’s Annual Report or Form 10-K for the fiscal year ending December 31, 2002.
Contact: Craig Martin
617.761.6729
MedQuist
CONTACT: Craig Martin, +1-617-761-6729, for MedQuist